Inventor · disambiguated record
Ulrich Ebert
Also filed as: EBERT ULRICH · EBERT ULRICH M
21 granted patents·12 pending applications·156 citations·filing 2004–2021
95Inventor score
Top patents by PatentIndex Score
33 records- 0190US8987419B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Mar 24, 2015·15 cites·11 claims
- 0290US8691224B2Anti-Aβ globulomer 5F7 antibodiesBARGHORN STEFAN·Filed 2006·Granted Apr 8, 2014·14 cites·16 claims
- 0390US8323651B2Antibodies to receptor of advanced glycation end products (RAGE) and uses thereofGU JIJIE·Filed 2009·Granted Dec 4, 2012·29 cites·12 claims
- 0489US7488733B26-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitorsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Feb 10, 2009·37 cites·8 claims
- 0588US8263558B2Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteinsHOLZMAN THOMAS F·Filed 2006·Granted Sep 11, 2012·23 cites·14 claims
- 0687US9359430B2Abeta conformer selective anti-Abeta globulomer monoclonal antibodiesABBVIE INC·Filed 2013·Granted Jun 7, 2016·4 cites·7 claims
- 0786US9394360B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 19, 2016·6 cites·2 claims
- 0885US10323084B2Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2017·Granted Jun 18, 2019·3 cites·16 claims
- 0985US8497072B2Amyloid-beta globulomer antibodiesHILLEN HEINZ·Filed 2006·Granted Jul 30, 2013·6 cites·18 claims
- 1083US9062101B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Jun 23, 2015·6 cites·43 claims
- 1180US8455626B2Aβ conformer selective anti-aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2007·Granted Jun 4, 2013·4 cites·13 claims
- 1277US10047121B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Aug 14, 2018·2 cites·18 claims
- 1376US2022017607A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2021·Application pending·0 cites
- 1475US9951125B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE INC·Filed 2016·Granted Apr 24, 2018·1 cites·19 claims
- 1574US10538581B2Anti-Aβ globulomer 4D10 antibodiesABBVIE INC·Filed 2016·Granted Jan 21, 2020·1 cites·17 claims
- 1672US9291621B2AGER-peptides and use thereofHAHN ALFRED·Filed 2006·Granted Mar 22, 2016·2 cites·9 claims
- 1770US8895004B2Method for the treatment of amyloidosesNIMMRICH VOLKER·Filed 2008·Granted Nov 25, 2014·2 cites·3 claims
- 1869US9394363B2Antibodies to receptor of advanced glycation end products (RAGE) and uses thereofABBVIE DEUTSCHLAND·Filed 2012·Granted Jul 19, 2016·1 cites·10 claims
- 1964US2015071915A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 2059US9540432B2Anti-Aβ globulomer 7C6 antibodiesABBVIE INC·Filed 2013·Granted Jan 10, 2017·0 cites·14 claims
- 2158US10208109B2Monoclonal antibodies against amyloid beta protein and uses thereofHILLEN HEINZ·Filed 2011·Granted Feb 19, 2019·0 cites·20 claims
- 2258US2009111838A16-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitorsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2358US2016159891A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2016·Application pending·0 cites
- 2457US8877190B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2011·Granted Nov 4, 2014·0 cites·5 claims
- 2554US2017008959A1Ager-peptides and use thereofABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 2653US2018094049A1Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2752US2010173828A1Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereofABBOTT GMBH & CO KG·Filed 2009·Application pending·0 cites
- 2850US9822171B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 21, 2017·0 cites·15 claims
- 2949US2009175847A1Humanized antibodies to ab (20-42) globulomer and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 3049US2009232801A1Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses ThereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 3148US2017002075A1Antibodies to receptor of advanced glycation end products (rage) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3244US2015079096A1Method for the treatment of amyloidosesABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3343US2009035295A1Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said AntibodiesABBOTT GMGH & CO KG·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Ebert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →